首页> Journal of molecular endocrinology> ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer.

ZMIZ1 enhances ERα-dependent expression of E2F2 in breast cancer.

导出 OA

翻译打印收藏纠错

第一作者： Weiye,Zhao

第一单位： Department of Biology, University of York, York, UK.

作者： Weiye,Zhao ^[1] ; Susanna F,Rose ^[1] ; Ryan,Blake ^[2] ; Aňze,Godicelj ^[3] ; Amy E,Cullen ^[2] ; Jack,Stenning ^[1] ; Lucy,Beevors ^[4] ; Marcel,Gehrung ^[2] ; Sanjeev,Kumar ^[5] ; Kamal,Kishore ^[2] ; Ashley,Sawle ^[2] ; Matthew,Eldridge ^[2] ; Federico M,Giorgi ^[6] ; Katherine S,Bridge ^[7] ; Florian,Markowetz ^[2] ; Andrew N,Holding ^[8]

作者单位： Department of Biology, University of York, York, UK. ^[1] CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. ^[2] Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Smith Building, Boston, Massachusetts, USA. ^[3] The Institute of Metabolism and Systems Research (IMSR), University of Birmingham, College of Medical and Dental Sciences, Birmingham, UK. ^[4] Chris O'Brien Lifehouse, Sydney, New South Wales, Australia. ^[5] Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy. ^[6] Department of Biology, University of York, York, UK.;York Biomedical Research Institute, University of York, York, UK. ^[7] Department of Biology, University of York, York, UK.;York Biomedical Research Institute, University of York, York, UK.;The Alan Turing Institute, Kings Cross, London, UK. ^[8]

关键词 E2F2 ZMIZ1 breast cancer cancer co-factors transcription nuclear receptors signalling patient outcome estrogen receptor